Mast cells are important modifiers of autoimmune disease: With so much evidence, why is there still controversy?

Frontiers in Immunology

Volumn 3, Issue JUN, 2012, Pages

  Brown, Melissa A ^a   Hatfield, Julianne K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmunity; Mast cell deficient mice; Mast cells; MC T cell crosstalk; Neutrophils

Indexed keywords

EID: 84869861620     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00147     Document Type: Review

References (194)

1. Abdollahi-Roodsaz, S., Joosten, L. A., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R., Heuvelmans Jacobs, M., Akira, S., Nicklin, M. J., RibeiroDias, F., and van den Berg, W. B. (2008). Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118, 205-216.
2. Abdul-Majid, K. B., Stefferl, A., Bourquin, C., Lassmann, H., Linington, C., Olsson, T., Kleinau, S., and Harris, R. A. (2002). Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55, 70-81.
3. Aloe, L., Probert, L., Kollias, G., Bracci Laudiero, L., Micera, A., Mollinari, C., and Levi-Montalcini, R. (1993). Level of nerve growth factor and distribution of mast cells in the synovium of tumour necrosis factor transgenic arthritic mice. Int. J. Tissue React. 15, 139-143.
4. Annibale, B., Negrini, R., Caruana, P., Lahner, E., Grossi, C., Bordi, C., and Delle Fave, G. (2001). Twothirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 6, 225-233.
5. Baba, T., Sonozaki, H., Seki, K., Uchiyama, M., Ikesawa, Y., and Toriisu, M. (1976). An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J. Immunol. 116, 112-116.
6. Bach, J. F., Bendelac, A., Brenner, M. B., Cantor, H., De Libero, G., Kronenberg, M., Lanier, L. L., Raulet, D. H., Shlomchik, M. J., and von Herrath, M. G. (2004). The role of innate immunity in autoimmunity. J. Exp. Med. 200, 1527-1531.
7. Backlund, J., Carlsen, S., Hoger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H., and Holmdahl, R. (2002). Predominant selection of T cells specific for the glycosylated collagen type II epitope (263270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 99, 9960-9965.
8. Baram, D., Vaday, G. G., Salamon, P., Drucker, I., Hershkoviz, R., and Mekori, Y. A. (2001). Human mast cells release metalloproteinase9 on contact with activated T cells: juxtacrine regulation by TNFalpha. J. Immunol. 167, 4008-4016.
9. Barnes, P. J. (2011). Pathophysiology of allergic inflammation. Immunol. Rev. 242, 31-50.
10. Bartholomew, J. S., Evanson, J. M., and Woolley, D. E. (1991). Serum IgE anticartilage collagen antibodies in rheumatoid patients. Rheumatol. Int. 11, 37-40.
11. Barzilai, O., Sherer, Y., Ram, M., Izhaky, D., Anaya, J. M., and Shoenfeld, Y. (2007). EpsteinBarr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann. N. Y. Acad. Sci. 1108, 567-577.
12. Bennett, J. L., Blanchet, M. R., Zhao, L., Zbytnuik, L., Antignano, F., Gold, M., Kubes, P., and McNagny, K. M. (2009). Bone marrowderived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J. Immunol. 182, 5507-5514.
13. Benoist, C., and Mathis, D. (2002). Mast cells in autoimmune disease. Nature 420, 875-878.
14. Bianchi, M. E. (2007). DAMPs, PAMPs, and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5.
15. Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hultner, L., and Rocken, M. (2000). Mast cells control neutrophil recruitment during T cellmediated delayedtype hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452.
16. Biesecker, G., Katz, S., and Koffler, D. (1981). Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J. Exp. Med. 154, 1779-1794.
17. Binstadt, B. A., Patel, P. R., Alencar, H., Nigrovic, P. A., Lee, D. M., Mahmood, U., Weissleder, R., Mathis, D., and Benoist, C. (2006). Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7, 284-292.
18. Bluestone, J. A., Herold, K., and Eisenbarth, G. (2010). Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464, 1293-1300.
19. Boos, L., Campbell, I. L., Ames, R., Wetsel, R. A., and Barnum, S. R. (2004). Deletion of the complement anaphylatoxin C3a receptor attenuates, where as ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J. Immunol. 173, 4708-4714.
20. Carlson, T., Kroenke, M., Rao, P., Lane, T. E., and Segal, B. (2008). The Th17ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205, 811-823.
21. Chen, M., Lam, B. K., Kanaoka, Y., Nigrovic, P. A., Audoly, L. P., Austen, K. F., and Lee, D. M. (2006). Neutrophilderived leukotriene B4 is required for inflammatory arthritis. J. Exp. Med. 203, 837-842.
22. Chen, R., Fairley, J. A., Zhao, M. L., Giudice, G. J., Zillikens, D., Diaz, L. A., and Liu, Z. (2002). Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophagemediated neutrophil infiltration depends on mast cell activation. J. Immunol. 169, 3987-3992.
23. Chen, R., Ning, G., Zhao, M. L., Fleming, M. G., Diaz, L. A., Werb, Z., and Liu, Z. (2001). Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108, 1151-1158.
24. Chervonsky, A. (2009). Innate receptors and microbes in induction of autoimmunity. Curr. Opin. Immunol. 21, 641-647.
25. Choe, J. Y., Crain, B., Wu, S. R., and Corr, M. (2003). Interleukin 1 recep tor dependence of serum transferred arthritis can be circumvented by toll like receptor 4 signaling. J. Exp. Med. 197, 537-542.
26. Concha, L. B., Chang, C. C., Szema, A. M., Dattwyler, R. J., and Carlson, H. E. (2004). IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy Asthma Proc. 25, 293-296.
27. Cook, H. T., and Botto, M. (2006). Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2, 330-337.
28. Cooper, A. L., Snowden, N., and Woolley, D. E. (1993). IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases. Scand. J. Rheumatol. 22, 207-214.
29. Corr, M., and Crain, B. (2002). The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis. J. Immunol. 169, 6604-6609.
30. Couser, W. G. (1985). Mechanisms of glomerular injury in immune complex disease. Kidney Int. 28, 569-583.
31. Couser, W. G., Baker, P. J., and Adler, S. (1985). Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int. 28, 879-890.
32. D'Auria, L., Pietravalle, M., Cordiali Fei, P., and Ameglio, F. (2000). Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and antibasement membrane zone antibodies. Exp. Dermatol. 9, 131-137.
33. Dawicki, W., and Marshall, J. S. (2007). New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19, 31-38.
34. de Vries, V. C., Pino-Lagos, K., Nowak, E. C., Bennett, K. A., Oliva, C., and Noelle, R. J. (2011). Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 35, 550-561.
35. D'Elios, M. M., Appelmelk, B. J., Amedei, A., Bergman, M. P., and Del Prete, G. (2004). Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends. Mol. Med. 10, 316-323.
36. Dietsch, G. N., and Hinrichs, D. J. (1989). The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142, 1476-1481.
37. Dimitriadou, V., Pang, X., and Theo harides, T. C. (2000). Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activa tion. Int. J. Immunopharmacol. 22, 673-684.
38. Dudeck, A., Dudeck, J., Scholten, J., Petzold, A., Surianarayanan, S., Kohler, A., Peschke, K., Vohringer, D., Waskow, C., Krieg, T., Muller, W., Waisman, A., Hartmann, K., Gunzer, M., and Roers, A. (2011). Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34, 973-984.
39. Dvorak, A. M., Mihm, M. C. Jr., Osage, J. E., Kwan, T. H., Austen, K. F., and Wintroub, B. U. (1982). Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J. Invest. Dermatol. 78, 91-101.
40. Fairley, J. A., Burnett, C. T., Fu, C. L., Larson, D. L., Fleming, M. G., and Giudice, G. J. (2007). A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE repro duces the early phase of lesion development in human skin grafted to nu/nu mice. J. Invest. Dermatol. 127, 2605-2611.
41. Falk, R. J., Dalmasso, A. P., Kim, Y., Tsai, C. H., Scheinman, J. I., Gewurz, H., and Michael, A. F. (1983). Neoanti gen of the polymerized ninth com ponent of complement. Character ization of a monoclonal antibody and immunohistochemical localiza tion in renal disease. J. Clin. Invest. 72, 560-573.
42. Feyerabend, T. B., Weiser, A., Tietz, A., Stassen, M., Harris, N., Kopf, M., Radermacher, P., Moller, P., Benoist, C., Mathis, D., Fehling, H. J., and Rodewald, H. R. (2011). Cremediated cell ablation con tests mast cell contribution in models of antibody and T cell mediated autoimmunity. Immunity 35, 832-844.
43. Fischer, M., and Ehlers, M. (2008). Toll like receptors in autoimmunity. Ann. N. Y. Acad. Sci. 1143, 21-34.
44. Forward, N. A., Furlong, S. J., Yang, Y., Lin, T. J., and Hoskin, D. W. (2009). Mast cells downregulate CD4+CD25+ T regulatory cell sup pressor function via histamine H1 receptor interaction. J. Immunol. 183, 3014-3022.
45. Fox, C. C., Jewell, S. D., and Whitacre, C. C. (1994). Rat peritoneal mast cells present antigen to a PPD specific T cell line. Cell. Immunol. 158, 253-264.
46. Frandji, P., Oskeritzian, C., Cacraci, F., Lapeyre, J., Peronet, R., David, B., Guillet, J.G., and Mecheri, S. (1993). Antigendependent stimula tion by bone marrowderived mast cells of MHC class IIrestricted T cell hybridoma. J. Immunol. 151, 6318-6328.
47. Frandji, P., Tkaczk, C., Oskeritzian, C., Lapeyre, J., Peronet, R., David, B., Guillet, J.G., and Mecheri, S. (1995). Presentation of soluble antigens by mast cells: upregulation by interleukin4 and granulocyte/macrophage colonystimulating factor and downregulation by interferonγ. Cell. Immunol. 163, 37-46.
48. Frandji, P., Tkaczyk, C., Oskeritzian, C., David, B., Desaymard, C., and Mecheri, S. (1996). Exogenous and endogenous antigens are dif ferentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol. 26, 2517-2528.
49. Fukuoka, Y., Xia, H. Z., Sanchez Munoz, L. B., Dellinger, A. L., Escribano, L., and Schwartz, L. B. (2008). Generation of anaphylatoxins by human betatryptase from C3, C4, and C5. J. Immunol. 180, 6307-6316.
50. Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M., and Tsai, M. (2005). Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786.
51. Galli, S. J., and Kitamura, Y. (1987). Genetically mastcelldeficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127, 191-198.
52. Gambuzza, M., Licata, N., Palella, E., Celi, D., Foti Cuzzola, V., Italiano, D., Marino, S., and Bramanti, P. (2011). Targeting Tolllike receptors: emerging therapeutics for multiple sclero sis management. J. Neuroimmunol. 239, 1-12.
53. Geoffrey, R., Jia, S., Kwitek, A. E., Woodliff, J., Ghosh, S., Lernmark, A., Wang, X., and Hessner, M. J. (2006). Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat. J. Immunol. 177, 7275-7286.
54. Ghohestani, R. F., Cozzani, E., Delaporte, E., Nicolas, J. F., Parodi, A., and Claudy, A. (1998). IgE antibodies in sera from patients with bullous pem phigoid are autoantibodies preferen tially directed against the 230kDa epidermal antigen (BP230). J. Clin. Immunol. 18, 202-209.
55. Goh, F. G., and Midwood, K. S. (2012). Intrinsic danger: activation of Tolllike receptors in rheumatoid arthritis. Rheumatology (Oxford) 51, 7-23.
56. Gregory, G. D., and Brown, M. A. (2006). Mast cells in allergy and autoimmunity: implications for adaptive immunity. Methods Mol. Biol. 315, 35-50.
57. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., and Pucillo, C. E. (2008). CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40 OX40L interaction. Immunity 29, 771-781.
58. Grimbaldeston, M. A., Chen, C. C., Piliponsky, A. M., Tsai, M., Tam, S. Y., and Galli, S. J. (2005). Mast celldeficient Wsash ckit mutant Kit Wsh/Wsh mice as a model for investigating mast cell biologyinvivo. Am. J. Pathol. 167, 835-848.
59. Hauser, S. L., and Oksenberg, J. R. (2006). The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61-76.
60. Heimbach, L., Li, Z., Berkowitz, P., Zhao, M., Li, N., Rubenstein, D. S., Diaz, L. A., and Liu, Z. (2011). The C5a receptor on mast cells is critical for the autoimmune skinblistering disease bullous pemphigoid. J. Biol. Chem. 286, 15003-15009.
61. Hershko, A. Y., and Rivera, J. (2010). Mast cell and T cell communication; amplification and control of adap tive immunity. Immunol. Lett. 128, 98-104.
62. Hoffmann, M. H., Skriner, K., Herman, S., Baumann, C., Steiner, C. W., Ospelt, C., Meyer, B., Gleiss, A., Pfatschbacher, J., Niederreiter, B., Tuncel, J., Zanoni, G., and Steiner, G. (2011). Nucleic acid stimulated antigenpresenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis. J. Autoimmun. 36, 288-300.
63. Hubner, M. P., Larson, D., Torrero, M. N., Mueller, E., Shi, Y., Killoran, K. E., and Mitre, E. (2011). AntiFcepsilonR1 antibody injec tions activate basophils and mast cells and delay type 1 diabetes onset in NOD mice. Clin. Immunol. 141, 205-217.
64. Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., Melendez, A. J., and McInnes, I. B. (2010). Mast cells express IL17A in rheuma toid arthritis synovium. J. Immunol. 184, 3336-3340.
65. Inamura, N., Mekori, Y. A., Bhattacharyya, S. P., Bianchine, P. J., and Metcalfe, D. D. (1998). Induction and enhancement of Fc(epsilon)RIdependent mast cell degranulation following coculture with activated T cells: dependency on ICAM1 and leukocyte functionassociated antigen (LFA) 1mediated heterotypic aggregation. J. Immunol. 160, 4026-4033.
66. Kakizoe, E., Li, S. H., Kobayashi, Y., Nishikori, Y., Dekio, S., and Okunishi, H. (1999). Increases in mast cells and chymase in fibroprolif erative paws of collageninduced arthritic mice. Inflamm. Res. 48, 318-324.
67. Kambayashi, T., Allenspach, E. J., Chang, J. T., Zou, T., Shoag, J. E., Reiner, S. L., Caton, A. J., and Koretzky, G. A. (2009). Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J. Immunol. 182, 4686-4695.
68. Kambayashi, T., Baranski, J. D., Baker, R. G., Zou, T., Allenspach, E. J., Shoag, J. E., Jones, P. L., and Koretzky, G. A. (2008). Indirect involve ment of allergencaptured mast cells in antigen presentation. Blood 111, 1489-1496.
69. Kaplan, M. J. (2011). Neutrophils in the pathogenesis and manifestations of SLE. Nat. Rev. Rheumatol. 7, 691-699.
70. Kashiwakura, J., Yokoi, H., Saito, H., and Okayama, Y. (2004). T cell prolif eration by direct crosstalk between OX40 ligand on human mast cells and OX40 on human T cells: com parison of gene expression profiles between human tonsillar and lung cultured mast cells. J. Immunol. 173, 5247-5257.
71. Kasperkiewicz, M., and Zillikens, D. (2007). The pathophysiology of bullous pemphigoid. Clin. Rev. Allergy Immunol. 33, 67-77.
72. Katayama, I., Doi, T., and Nishioka, K. (1984). High histamine level in the blister fluid of bullous pem phigoid. Arch. Dermatol. Res. 276, 126-127.
73. Katz, H. R., and Austen, K. F. (2011). Mast cell deficiency, a game of kit and mouse. Immunity 35, 668-670.
74. Kawai, T., and Akira, S. (2011). Toll like receptors and their crosstalk with other innate receptors in infec tion and immunity. Immunity 34, 637-650.
75. Kivity, S., Agmon-Levin, N., Blank, M., and Shoenfeld, Y. (2009). Infections and autoimmunity - friends or foes? Trends Immunol. 30, 409-414.
76. Kufer, T. A., and Sansonetti, P. J. (2011). NLR functions beyond pathogen recognition. Nat. Immunol. 12, 121-128.
77. Kumar, V., and Sharma, A. (2010). Neutrophils: cinderella of innate immune system. Int. Immunophar macol. 10, 1325-1334.
78. Kwok, S. K., Cho, M. L., Her, Y. M., Oh, H. J., Park, M. K., Lee, S. Y., Woo, Y. J., Ju, J. H., Park, K. S., Kim, H. Y., and Park, S. H. (2012). TLR2 ligation induces the production of IL23/IL 17 via IL6, STAT3 and NFkB pathway in patients with primary Sjo gren's syndrome. Arthritis Res. Ther. 14, R64.
79. Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., and Brenner, M. B. (2002). Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692.
80. Lee, D. M., and Weinblatt, M. E. (2001). Rheumatoid arthritis. Lancet 358, 903-911.
81. Li, Q., Ujiie, H., Shibaki, A., Wang, G., Moriuchi, R., Qiao, H. J., Morioka, H., Shinkuma, S., Natsuga, K., Long, H. A., Nishie, W., and Shimizu, H. (2010). Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model. J. Immunol. 185, 7746-7755.
82. Lien, E., and Zipris, D. (2009). The role of Tolllike receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 9, 52-68.
83. Lilla, J. N., Chen, C. C., Mukai, K., Ben-Barak, M. J., Franco, C. B., Kalesnikoff, J., Yu, M., Tsai, M., Piliponsky, A. M., and Galli, S. J. (2011). Reduced mast cell and basophil numbers and function in Cpa3Cre; Mcl1fl/fl mice. Blood 118, 6930-6938.
84. Liu, Z., Sui, W., Zhao, M., Li, Z., Li, N., Thresher, R., Giudice, G. J., Fairley, J. A., Sitaru, C., Zillikens, D., Ning, G., Marinkovich, M. P., and Diaz, L. A. (2008). Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J. Autoimmun. 31, 331-338.
85. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S. J., Oksenberg, J. R., Raine, C. S., Heller, R., and Steinman, L. (2002). Gene microarray analysis of multiple sclerosis lesions yield new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
86. Lohr, J., Knoechel, B., Nagabhushanam, V., and Abbas, A. K. (2005). T cell tolerance and autoimmunity to systemic and tissuerestricted selfantigens. Immunol. Rev. 204, 116-127.
87. Louvet, C., Szot, G. L., Lang, J., Lee, M. R., Martinier, N., Bollag, G., Zhu, S., Weiss, A., and Bluestone, J. A. (2008). Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 105, 18895-18900.
88. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., Strom, T. B., Zheng, X. X., and Noelle, R. J. (2006). Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002.
89. Maciejewska Rodrigues, H., Jungel, A., Gay, R. E., and Gay, S. (2009). Innate immunity, epigenetics and autoimmunity in rheuma toid arthritis. Mol. Immunol. 47, 12-18.
90. Mackay, I. R., and Anderson, W. H. (2010). What's in a name? Experimental encephalomyelitis: "allergic" or "autoimmune." J. Neuroimmunol. 223, 1-4.
91. Mackworth-Young, C. G., Chan, J. K., Bunn, C. C., Hughes, G. R., and Gharavi, A. E. (1986). Complement fixation by antids-DNA antibodies in SLE: measurement by radioim munoassay and relationship with disease activity. Ann. Rheum. Dis. 45, 314-318.
92. Malaviya, R., Ikeda, T., Ross, E., and Abraham, S. (1996a). Mast cell modulation of neutrophil influx and bac terial clearance at sites of infection through TNFalpha. Nature 381, 77-80.
93. Malaviya, R., Twesten, N. J., Ross, E. A., Abraham, S. N., and Pfeifer, J. D. (1996b). Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156, 1490-1496.
94. Mantovani, A., Cassatella, M. A., Costantini, C., and Jaillon, S. (2011). Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531.
95. Marek, L. R., and Kagan, J. C. (2012). Deciphering the function of nucleicacid sensing TLRs one regulatory step at a time. Front. Biosci. 17, 2060-2068.
96. Marshak-Rothstein, A., and Ohashi, P. S. (2007). Intricate connections between innate and adaptive autoimmunity. Curr. Opin. Immunol. 19, 603-605.
97. Marshall, J. S. (2004). Mastcell responses to pathogens. Nat. Rev. Immunol. 4, 787-799.
98. Marshall, J. S., McCurdy, J. D., and Olynych, T. (2003a). Toll like receptormediated activation of mast cells: implications for allergic disease? Int. Arch. Allergy Immunol. 132, 87-97.
99. Marshall, J. S., King, C.A., and McCurdy, J. D. (2003b). Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr. Pharm. Des. 9, 11-24.
100. Marta, M., Meier, U. C., and Lobell, A. (2009). Regulation of autoimmune encephalomyelitis by tolllike receptors. Autoimmun. Rev. 8, 506-509.
101. McIlroy, A., Caron, G., Blanchard, S., Fremaux, I., Duluc, D., Delneste, Y., Chevailler, A., and Jeannin, P. (2006). Histamine and prostaglandin E up regulate the production of Th2 attracting chemokines (CCL17 and CCL22) and downregulate IFN gammainduced CXCL10 production by immature human dendritic cells. Immunology 117, 507-516.
102. Mekori, Y. A., and Metcalfe, D. D. (1999). Mast cellT cell interactions. J. Allergy Clin. Immunol. 104, 517-523.
103. Mercer-Jones, M. A., Shrotri, M. S., Heinzelmann, M., Peyton, J. C., and Cheadle, W. G. (1999). Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein2 and mast cells in experi mental peritonitis. J. Leukoc. Biol. 65, 249-255.
104. Metcalfe, R., Jordan, N., Watson, P., Gullu, S., Wiltshire, M., Crisp, M., Evans, C., Weetman, A., and Ludgate, M. (2002). Demonstration of immunoglobulin G, A, and E autoantibodies to the human thy rotropin receptor using flow cytom etry. J. Clin. Endocrinol. Metab. 87, 1754-1761.
105. Metz, M., Grimbaldeston, M. A., Nakae, S., Piliponsky, A. M., Tsai, M., and Galli, S. J. (2007). Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev. 217, 304-328.
106. Mills, K. H. (2011). TLRdependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11, 807-822.
107. Mix, E., Meyer-Rienecker, H., Hartung, H. P., and Zettl, U. K. (2010). Animal models of multiple sclerosis - poten tials and limitations. Prog. Neurobiol. 92, 386-404.
108. Miyajima, I., Dombrowicz, D., Martin, T. R., Ravetch, J. V., Kinet, J. P., and Galli, S. J. (1997). Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE or IgG1 dependent passive anaphylaxis. J. Clin. Invest. 99, 901-914.
109. Monach, P. A., Nigrovic, P. A., Chen, M., Hock, H., Lee, D. M., Benoist, C., and Mathis, D. (2010). Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lympho cyte functionassociated antigen 1. Arthritis Rheum. 62, 753-764.
110. Morgan, B. P., Griffiths, M., Khanom, H., Taylor, S. M., and Neal, J. W. (2004). Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin. Exp. Immunol. 138, 430-438.
111. Mrabet-Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T., and Maurer, M. (2009). Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 18, 437-444.
112. Nakae, S., Lunderius, C., Ho, L. H., Schafer, B., Tsai, M., and Galli, S. J. (2007a). TNF can contribute to mul tiple features of ovalbumininduced allergic inflammation of the airways in mice. J. Allergy Clin. Immunol. 119, 680-686.
113. Nakae, S., Suto, H., Berry, G. J., and Galli, S. J. (2007b). Mast cellderived TNF can promote Th17 celldependent neutrophil recruitment in ovalbumin challenged OTII mice. Blood 109, 3640-3648.
114. Nakae, S., Ho, L. H., Yu, M., Monteforte, R., Iikura, M., Suto, H., and Galli, S. J. (2007c). Mast cellderived TNF contributes to airway hyperreactiv ity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120, 48-55.
115. Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M., and Galli, S. J. (2006). Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176, 2238-2248.
116. Nakae, S., Suto, H., Kakurai, M., Sedgwick, J. D., Tsai, M., and Galli, S. J. (2005). Mast cells enhance T cell activation: importance of mast cell derived TNF. Proc. Natl. Acad. Sci. U.S.A. 102, 6467-6472.
117. Nakamura, Y., Kambe, N., Saito, M., Nishikomori, R., Kim, Y. G., Murakami, M., Nunez, G., and Matsue, H. (2009). Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamineindependent urticaria. J. Exp. Med. 206, 1037-1046.
118. Navi, D., Saegusa, J., and Liu, F. T. (2007). Mast cells and immunological skin diseases. Clin. Rev. Allergy Immunol. 33, 144-155.
119. Nigrovic, P. A., Binstadt, B. A., Monach, P. A., Johnsen, A., Gurish, M., Iwakura, Y., Benoist, C., Mathis, D., and Lee, D. M. (2007). Mast cells contribute to initiation of autoantibody-mediated arthritis via IL1. Proc. Natl. Acad. Sci. U.S.A. 104, 2325-2330.
120. Nigrovic, P. A., Gray, D. H., Jones, T., Hallgren, J., Kuo, F. C., Chaletzky, B., Gurish, M., Mathis, D., Benoist, C., and Lee, D. M. (2008). Genetic inver sion in mast celldeficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aber rancy. Am. J. Pathol. 173, 1693-1701.
121. Nigrovic, P. A., and Lee, D. M. (2007). Synovial mast cells: role in acute and chronic arthritis. Immunol. Rev. 217, 19-37.
122. Nigrovic, P. A., Malbec, O., Lu, B., Markiewski, M. M., Kepley, C., Gerard, N., Gerard, C., Daeron, M., and Lee, D. M. (2010). C5a recep tor enables participation of mast cells in immune complex arthritis independently of Fcgamma recep tor modulation. Arthritis Rheum. 62, 3322-3333.
123. Nurieva, R. I., Liu, X., and Dong, C. (2011). Molecular mechanisms of T cell tolerance. Immunol. Rev. 241, 133-144.
124. Oikarinen, A. I., Zone, J. J., Ahmed, A. R., Kiistala, U., and Uitto, J. (1983). Demonstration of collage nase and elastase activities in the blister fluids from bullous skin dis eases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J. Invest. Dermatol. 81, 261-266.
125. Otsuka, A., Kubo, M., Honda, T., Egawa, G., Nakajima, S., Tanizaki, H., Kim, B., Matsuoka, S., Watanabe, T., Nakae, S., Miyachi, Y., and Kabashima, K. (2011). Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS ONE 6, e25538. doi:10.1371/jour nal.pone.0025538.
126. Palmer, H. S., Kelso, E. B., Lockhart, J. C., Sommerhoff, C. P., Plevin, R., Goh, F. G., and Ferrell, W. R. (2007). Proteaseactivated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum. 56, 3532-3540.
127. Patterson, R., Pateras, V., Grammer, L. C., and Harris, K. E. (1986). Human antibodies against formaldehyde human serum albumin conjugates or human serum albumin in individuals exposed to formaldehyde. Int. Arch. Allergy Appl. Immunol. 79, 53-59.
128. Pedotti, R., DeVoss, J. J., Youssef, S., Mitchell, D., Wedemeyer, J., Madanat, R., Garren, H., Fontoura, P., Tsai, M., Galli, S. J., Sobel, R. A., and Steinman, L. (2003). Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. U.S.A. 100, 1867-1872.
129. Pedotti, R., Mitchell, D., Wedemeyer, J., Karpuj, M., Chabas, D., Hattab, E. M., Tsai, M., Galli, S. J., and Steinman, L. (2001). An unexpected version of horror autotoxicus: anaphy lactic shock to a selfpeptide. Nat. Immunol. 2, 216-222.
130. Pennell, L. M., Galligan, C. L., and Fish, E. N. (2012). Sex affects immunity. J. Autoimmun. 38, 282-291.
131. Perkinson, D. T., Baker, P. J., Couser, W. G., Johnson, R. J., and Adler, S. (1985). Membrane attack complex deposition in experimental glomerular injury. Am. J. Pathol. 120, 121-128.
132. Permin, H., and Wiik, A. (1978). The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemiclupus erythematosus. Acta Pathol. Microbiol. Scand. C 86C, 245-249.
133. Piccinini, A. M., and Midwood, K. S. (2010). DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010. doi: 10.1155/2010/672395.
134. Piconese, S., Costanza, M., Musio, S., Tripodo, C., Poliani, P. L., Gri, G., Burocchi, A., Pittoni, P., Gorzanelli, A., Colombo, M. P., and Pedotti, R. (2011). Exacerbated experimen tal autoimmune encephalomyelitis in mastcelldeficient Kit Wsh/W sh mice. Lab. Invest. 91, 627-641.
135. Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E., and Colombo, M. P. (2009). Mast cells counteract regulatory Tcell suppression through interleukin6 and OX40/OX40L axis toward Th17cell differentiation. Blood 114, 2639-2648.
136. Pillai, S., Mattoo, H., and Cariappa, A. (2011). B cells and autoimmunity. Curr. Opin. Immunol. 23, 721-731.
137. Pimentel, T. A., Sampaio, A. L., D'Acquisto, F., Perretti, M., and Oliani, S. M. (2011). An essential role for mast cells as modulators of neutrophils influx in collageninduced arthritis in the mouse. Lab. Invest. 91, 33-42.
138. Pisetsky, D. S. (2008). The role of innate immunity in the induction of autoimmunity. Autoimmun. Rev. 8, 69-72.
139. Pitman, N., Asquith, D. L., Murphy, G., Liew, F. Y., and McInnes, I. B. (2011). Collageninduced arthritis is not impaired in mast cell deficientmice. Ann. Rheum. Dis. 70, 1170-1171.
140. Rai, E., and Wakeland, E. K. (2011). Genetic predisposition to autoimmunity - what have we learned? Semin. Immunol. 23, 67-83.
141. Ramaglia, V., Hughes, T. R., Donev, R. M., Ruseva, M. M., Wu, X., Huitinga, I., Baas, F., Neal, J. W., and Morgan, B. P. (2012). C3 dependent mechanism of microglial priming relevant to multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 109, 965-970.
142. Ramos, B. F., Zhang, Y., and Jakschik, B. A. (1994). Neutrophil elicitation in the reverse passive Arthus reac tion. Complementdependent and independent mast cell involvement. J. Immunol. 152, 1380-1384.
143. Ramos, B. F., Zhang, Y., Qureshi, R., and Jakschik, B. A. (1991). Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complexinduced peritonitis in mice. J. Immunol. 147, 1636-1641.
144. Ramos, T. N., Wohler, J. E., and Barnum, S. R. (2009). Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis. Neurosci. Lett. 467, 234-236.
145. Rao, K. N., and Brown, M. A. (2008). Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. N. Y. Acad. Sci. 1143, 83-104.
146. Reiman, R., Gerard, C., Campbell, I. L., and Barnum, S. R. (2002). Disrup tion of the C5a receptor genefails to protect against experimental allergic encephalomyelitis. Eur. J. Immunol. 32, 1157-1163.
147. Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., and Morgan, N. G. (2009). The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52, 1143-1151.
148. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J. D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785-797.
149. Robbie-Ryan, M., Tanzola, M. B., Secor, V. H., and Brown, M. A. (2003). Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170, 1630-1634.
150. Robson, M. G., Cook, H. T., Pusey, C. D., Walport, M. J., and Davies, K. A. (2003). Antibodymediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background. Clin. Exp. Immunol. 133, 326-333.
151. Ronaghy, A., Prakken, B. J., Takabayashi, K., Firestein, G. S., Boyle, D., Zvailfler, N. J., Roord, S. T., Albani, S., Carson, D. A., and Raz, E. (2002). Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J. Immunol. 168, 51-56.
152. Rothfield, N. F., and Stollar, B. D. (1967). The relation of immunoglobulin class, pattern of antinuclear anti-body, and complement-fixing anti-bodies to DNA in sera from patients with systemic lupus erythematosus. J. Clin. Invest. 46, 1785-1794.
153. Rozniecki, J. J., Hauser, S. L., Stein, M., Lincoln, R., and Theoharides, T. C. (1995). Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63-66.
154. Rubtsov, A. V., Rubtsova, K., Kappler, J. W., and Marrack, P. (2010). Genetic and hormonal factors in femalebiased autoimmunity. Autoimmun. Rev. 9, 494-498.
155. Salamon, P., Shoham, N. G., Gavrieli, R., Wolach, B., and Mekori, Y. A. (2005). Human mast cells release Interleukin8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60, 1316-1319.
156. Salamon, P., Shoham, N. G., Puxeddu, I., Paitan, Y., Levi-Schaffer, F., and Mekori, Y. A. (2008). Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. J. Allergy Clin. Immunol. 121, 448-455 e5.
157. Sawamukai, N., Yukawa, S., Saito, K., Nakayamada, S., Kambayashi, T., and Tanaka, Y. (2010). Mast cell derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rhomediated signaling. Arthritis Rheum. 62, 952-959.
158. Sayed, B. A., Christy, A., Quirion, M. R., and Brown, M. A. (2008). The master switch: the role of mast cells in autoimmunity and tolerance. Annu. Rev. Immunol. 26, 705-739.
159. Sayed, B. A., Christy, A. L., Walker, M. E., and Brown, M. A. (2010). Meningeal mast cells affect early T cell central nervous system infiltration and bloodbrain barrier integrity through TNF: a role for neutrophil recruitment? J. Immunol. 184, 6891-6900.
160. Sayed, B. A., Walker, M. E., and Brown, M. A. (2011). Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 186, 3294-3298.
161. Schwartz, L. B., Kawahara, M. S., Hugli, T. E., Vik, D., Fearon, D. T., and Austen, K. F. (1983). Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J. Immunol. 130, 1891-1895.
162. Secor, V. H., Secor, W. E., Gutekunst, C. A., and Brown, M. A. (2000). Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813-822.
163. Shin, K., Gurish, M. F., Friend, D. S., Pemberton, A. D., Thornton, E. M., Miller, H. R., and Lee, D. M. (2006). Lymphocyteindependent connective tissue mast cells populate murine synovium. Arthritis Rheum. 54, 2863-2871.
164. Shin, K., Nigrovic, P. A., Crish, J., Boilard, E., McNeil, H. P., Larabee, K. S., Adachi, R., Gurish, M. F., Gobezie, R., Stevens, R. L., and Lee, D. M. (2009). Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J. Immunol. 182, 647-656.
165. Smith, C. E., Eagar, T. N., Strominger, J. L., and Miller, S. D. (2005). Differential induction of IgEmediated anaphylaxis after soluble vs. cellbound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 102, 9595-9600.
166. Sospedra, M., and Martin, R. (2005). Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747.
167. Spachidou, M. P., Bourazopoulou, E., Maratheftis, C. I., Kapsogeorgou, E. K., Moutsopoulos, H. M., Tzioufas, A. G., and Manoussakis, M. N. (2007). Expression of functional Tolllike receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin. Exp. Immunol. 147, 497-503.
168. Spitzauer, S., Schweiger, C., Sperr, W. R., Pandjaitan, B., Valent, P., Muhl, S., Ebner, C., Scheiner, O., Kraft, D., Rumpold, H., and Valenta, R. (1994). Molecular characterization of dog albumin as a crossreactive allergen. J. Allergy Clin. Immunol. 93, 614-627.
169. Stahle-Backdahl, M., Inoue, M., Guidice, G. J., and Parks, W. C. (1994). 92kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180kD bullous pemphigoid autoantigen. J. Clin. Invest. 93, 2022-2030.
170. Stelekati, E., Bahri, R., D'Orlando, O., Orinska, Z., Mittrucker, H. W., Langenhaun, R., Glatzel, M., Bollinger, A., Paus, R., and Bulfone-Paus, S. (2009). Mast cellmediated antigen presentation regulates CD8+ Tcell effector functions. Immunity 31, 665-676.
171. Stelekati, E., Orinska, Z., and Bulfone Paus, S. (2007). Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212, 505-519.
172. Stopfer, P., Mannel, D. N., and Hehlgans, T. (2004). Lymphotoxin beta receptor activation by activated T cells induces cytokine release from mouse bone marrow-derived mast cells. J. Immunol. 172, 7459-7465.
173. Tanzola, M. B., Robbie-Ryan, M., Gutekunst, C. A., and Brown, M. A. (2003). Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171, 4385-4391.
174. Tenner, A. J. (2004). Influence of innate immune responses on autoimmunity. Autoimmunity 37, 83-84.
175. Touil, T., Fitzgerald, D., Zhang, G. X., Rostami, A., and Gran, B. (2006). Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFNbeta. J. Immunol. 177, 7505-7509.
176. Tuomisto, L., Kilpelainen, H., and Riekkinen, P. (1983). Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 13,255-257.
177. Urich, E., Gutcher, I., Prinz, M., and Becher, B. (2006). Autoantibody-mediated demyelination depends on complement activation but not activatory Fcreceptors. Proc. Natl. Acad. Sci. U.S.A. 103, 18697-18702.
178. Valenta, R., Duchene, M., Pettenburger, K., Sillaber, C., Valent, P., Bettelheim, P., Breitenbach, M., Rumpold, H., Kraft, D., and Scheiner, O. (1991). Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 253, 557-560.
179. Valenta, R., Mittermann, I., Werfel, T., Garn, H., and Renz, H. (2009). Linking allergy to autoimmune disease. Trends Immunol. 30, 109-116.
180. van den Broek, M. F., van den Berg, W. B., and van de Putte, L. B. (1988). The role of mast cells in antigen induced arthritis in mice. J. Rheuma tol. 15, 544-551.
181. Verri, W.A. Jr., Souto, F.O., Vieira, S. M., Almeida, S. C., Fukada, S. Y., Xu, D., Alves-Filho, J. C., Cunha, T. M., Guerrero, A. T., Mattos-Guimaraes, R. B., Oliveira, F. R., Teixeira, M. M., Silva, J. S., McInnes, I. B., Ferreira, S. H., Louzada-Junior, P., Liew, F. Y., and Cunha, F. Q. (2010). IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann. Rheum. Dis. 69, 1697-1703.
182. Walker, M. E., Hatfield, J. K., and Brown, M. A. (2011). New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim. Biophys. Acta. 1822, 57-65.
183. Wang, Y., and Thorlacius, H. (2005). Mast cellderived tumor necrosis factoralpha mediates macrophage inflammatory protein2induced recruitment of neutrophils in mice. Br. J. Pharmacol. 145, 1062-1068.
184. Warde, N. (2011). Autoimmunity: the role of neutrophils in SLE: untangling the NET. Nat. Rev. Rheumatol. 7, 252.
185. Weerth, S. H., Rus, H., Shin, M. L., and Raine, C. S. (2003). Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am. J. Pathol. 163, 1069-1080.
186. Wipke, B. T., Wang, Z., Kim, J., McCarthy, T. J., and Allen, P. M. (2002). Dynamic visualization of a jointspecific autoimmune response through positron emission tomography. Nat. Immunol. 3, 366-372.
187. Wipke, B. T., Wang, Z., Nagengast, W., Reichert, D. E., and Allen, P. M. (2004). Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J. Immunol. 172, 7694-7702.
188. Wyatt, R. J., McAdams, A. J., Forristal, J., Snyder, J., and West, C. D. (1979). Glomerular deposition of complementcontrol proteins in acute and chronic glomerulonephritis. Kidney Int. 16, 505-512.
189. Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N., McInnes, I. B., and Liew, F. Y. (2008). IL33 exacerbates antigeninduced arthritis by activating mast cells. Proc. Natl. Acad. Sci. U.S.A. 105, 10913-10918.
190. Xu, D., Jiang, H. R., Li, Y., Pushparaj, P. N., Kurowska-Stolarska, M., Leung, B. P., Mu, R., Tay, H. K., McKenzie, A. N., McInnes, I. B., Melendez, A. J., and Liew, F. Y. (2010). IL33 exacerbates autoantibody induced arthritis. J. Immunol. 184, 2620-2626.
191. Zhang, Q., Itagaki, K., and Hauser, C. J. (2010). Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 34, 55-59.
192. Zhang, Y., Ramos, B. F., Jakschik, B., Baganoff, M. P., Deppeler, C. L., Meyer, D. M., Widomski, D. L., Fretland, D. J., and Bolanowski, M. A. (1995). Interleukin 8 and mast cellgenerated tumor necrosis factoralpha in neutrophil recruitment. Inflammation 19, 119-132.
193. Zhang, Y., Ramos, B. F., and Jakschik, B.A. (1992). Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258, 1957-1959.
194. Zhou, J. S., Xing, W., Friend, D. S., Austen, K. F., and Katz, H. R. (2007). Mast cell deficiency in Kit(Wsh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204, 2797-2802.